does semaglutide cause heart palpitations GLP-1 Agonists and Rate Semaglutide cardiovascular outcomes align more

After 4 to 6 weeks, your leg should be able to handle your full body weight

Read in context, it is a secondary, exploratory outcome from a Phase 2 trial whose primary endpoint, change in cerebral glucose metabolism, was negative, and whose cognitive signal was modest

A more recent review describes this as a bidirectional relationship: GLP-1 drugs can shift the microbiome, and a person's existing microbiome may also predict how well they respond to the medication ( Frontiers in Endocrinology , 2026)

This makes it a strong opportunity for professionals planning to start or expand their work in the ophthalmic segment through an Ophthalmic PCD Pharma Franchise

Gut microbiota and incretin hormones Emerging research reveals complex relationships between gut bacteria composition and GLP-1 production